Safety and efficacy of 9R live attenuated vaccine against fowl typhoid in partridge's species.

Vaccine

Research and Development, MCI Santé Animale, Lot. 157, Z. I., Sud-Ouest (ERAC) B.P: 278, Mohammedia 28810, Morocco. Electronic address:

Published: December 2024

Fowl typhoid is a significant avian disease worldwide affecting mainly chickens, turkeys and other bird species, such as partridges. In Morocco, the disease causes a high mortality rate in farmed partridges. Vaccination of partridges is a priority to preserve the breed however; the vaccine has never been evaluated in this species. The study was conducted to assess safety and efficacy of a locally produced Salmonella 9R live vaccine in partridges. Groups of vaccinated partridges received the vaccine at 6 weeks of age, followed by a second injection 6 weeks after. The challenge test was performed at 14 weeks with Salmonella gallinarum MSG1 virulent strain. The challenge demonstrated 65 % protection in vaccinated challenged partridges, with a reduction in organ invasion compared to unvaccinated control birds, which exhibited 70,6 % mortality. The live attenuated 9R vaccine, could be safely used to reduce flock losses and contribute to the reduction of infection.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2024.126413DOI Listing

Publication Analysis

Top Keywords

safety efficacy
8
live attenuated
8
attenuated vaccine
8
fowl typhoid
8
partridges
6
vaccine
5
efficacy live
4
vaccine fowl
4
typhoid partridge's
4
partridge's species
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!